Last reviewed · How we verify

NCT04455165: RVAOMITAVA

Factors Influencing Morbi-mortality in Right Anterior Minithoracotomy Approch for Aortic Valve Replacement

Completed Last updated 7 July 2020
What this trial tests

trial testing Aortic valve replacement in Aortic Valve Disease in 300 participants. Completed in 29 June 2020.

Timeline
29 June 2020
Primary endpoint
29 June 2020
29 June 2020

Quick facts

Lead sponsorCentre Hospitalier La Chartreuse
StatusCompleted
Study typeOBSERVATIONAL
Enrollment300
Start date29 June 2020
Primary completion29 June 2020
Estimated completion29 June 2020
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier La Chartreuse

Who can join

Adults 18 to 99, any sex, with Aortic Valve Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Since 2009, positive experiences with right anterior minithoracotomy as an approach to aortic valve replacement are extensively practiced in our institution. The primary disease process for which patients are referred remains aortic stenosis. But more and more, we met older patients with both aortic stenosis and other cardiac pathology (coronary artery disease, other valvulopathy...). Even if minimally invasive valve surgery has been demonstrated to significantly improve postoperative course (reduced blood transfusion, pain, hospital lengths of stay) and to enhance postoperative recovery, when compared with a median sternotomy, it is however important to have medical data and statistics in order to better understand the factors influencing morbi-mortality and thereby to continue this improvement.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Aortic valve replacement

Trials testing the same drug.

Other recruiting trials for Aortic Valve Disease

Currently open trials in the same condition.

Other Centre Hospitalier La Chartreuse trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04455165.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing